Beta risk, also known as the risk of a Type II error, is the chance of failing to reject the null hypothesis when it is actually false. This means the test misses a real effect, concluding that no difference exists when in fact it does.
In hypothesis testing, the null hypothesis (H0) assumes no effect or difference. A Type II error occurs when the test lacks enough statistical power to detect a true effect, leading to a false negative result.
In medicine, a Type II error could mean failing to detect that a new drug is effective, potentially delaying treatment. In business, it could mean overlooking customer dissatisfaction because a survey was too small to reveal the problem.
Researchers reduce beta risk by:
Beta risk highlights the importance of statistical power in research. Balancing alpha risk (false positives) and beta risk (false negatives) ensures reliable results. While lowering alpha reduces false positives, it can increase beta unless sample sizes are adjusted. Managing this trade-off is key to sound decision-making.